Tokyo Tape
Sign in
← Kohjin Bio

Half-year report · HY

177A.TEDINET S100X2IH
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.5bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥5.2bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥2.5bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥258m2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥380m2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥272m2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥1.1bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥417m2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥274m2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥367m2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥202m2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥795m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥277m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥202m2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥277m2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥8.8bnat 2025-09-30Cons.Assets
Total assets¥9.1bnat 2025-03-31Cons.Assets
Total assets¥8.5bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥3.0bnat 2025-09-30Cons.Liabilities
Total liabilities¥3.3bnat 2025-03-31Cons.Liabilities
Net assets / equity¥5.8bnat 2025-09-30Cons.Net assets
Net assets / equity¥5.8bnat 2025-03-31Cons.Net assets
Net assets / equity¥5.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥3.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥2.4bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.3bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥202m2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥916m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥518m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥518m2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥467m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥220m2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥39.532025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥157.572024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥55.72024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio65.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio63.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.0%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2025-04-01 → 2025-09-30−¥283m
Cell Process Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥536m
Cell Process Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥536m
Cell Process Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥76m
Microbiological Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥686m
Microbiological Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥686m
Microbiological Businessreportable segmentsegment profit2025-04-01 → 2025-09-30−¥36m
Tissue Culture Businessreportable segmentrevenue2025-04-01 → 2025-09-30¥1.3bn
Tissue Culture Businessreportable segmentrevenue external2025-04-01 → 2025-09-30¥1.3bn
Tissue Culture Businessreportable segmentsegment profit2025-04-01 → 2025-09-30¥501m
—segment totalrevenue2025-04-01 → 2025-09-30¥2.5bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥2.5bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥541m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥265m
Cell Process Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥630m
Cell Process Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥630m
Cell Process Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥191m
Microbiological Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥777m
Microbiological Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥777m
Microbiological Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥104m
Tissue Culture Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
Tissue Culture Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
Tissue Culture Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥350m
—segment totalrevenue2024-04-01 → 2024-09-30¥2.5bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥2.5bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥645m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Valuation difference on available for sale securitiesPrior1YearInstant3427000JPY
Valuation difference on available for sale securitiesInterimInstant3741000JPY
Foreign currency translation adjustmentPrior1YearInstant106204000JPY
Foreign currency translation adjustmentInterimInstant57874000JPY
Valuation and translation adjustmentsPrior1YearInstant109631000JPY
Valuation and translation adjustmentsInterimInstant61615000JPY
Net assetsPrior1YearInstant5781821000JPY
Net assetsInterimInstant5813178000JPY
Liabilities and net assetsPrior1YearInstant9066648000JPY
Liabilities and net assetsInterimInstant8843105000JPY
Net salesPrior1InterimDuration2507586000JPY
Net salesInterimDuration2504480000JPY
Cost of salesPrior1InterimDuration1448523000JPY
Cost of salesInterimDuration1491859000JPY
Gross profitPrior1InterimDuration1059062000JPY
Gross profitInterimDuration1012620000JPY
Selling general and administrative expensesPrior1InterimDuration679280000JPY
Selling general and administrative expensesInterimDuration754967000JPY
Operating incomePrior1InterimDuration379782000JPY
Operating incomeInterimDuration257653000JPY
Interest income noiPrior1InterimDuration524000JPY
Interest income noiInterimDuration2441000JPY
Dividends income noiPrior1InterimDuration84000JPY
Dividends income noiInterimDuration151000JPY
Rent income noiPrior1InterimDuration5618000JPY
Rent income noiInterimDuration5618000JPY
Equity in earnings of affiliates noiPrior1InterimDuration55988000JPY
Equity in earnings of affiliates noiInterimDuration45969000JPY
Other noiPrior1InterimDuration3636000JPY
Other noiInterimDuration1036000JPY
Non operating incomePrior1InterimDuration65851000JPY
Non operating incomeInterimDuration55216000JPY
Interest expenses noePrior1InterimDuration14325000JPY
Interest expenses noeInterimDuration19225000JPY
Commission fee noePrior1InterimDuration10070000JPY
Commission fee noeInterimDuration1504000JPY
Compensation expenses noePrior1InterimDuration－JPY
Compensation expenses noeInterimDuration14634000JPY
Other noePrior1InterimDuration4358000JPY
Other noeInterimDuration5492000JPY
Non operating expensesPrior1InterimDuration28754000JPY
Non operating expensesInterimDuration40856000JPY
Ordinary incomePrior1InterimDuration416879000JPY
Ordinary incomeInterimDuration272013000JPY
Gain on sales of noncurrent assets eiPrior1InterimDuration1608000JPY
Gain on sales of noncurrent assets eiInterimDuration－JPY
Subsidy eiPrior1InterimDuration－JPY
Subsidy eiInterimDuration11694000JPY
Extraordinary incomePrior1InterimDuration1608000JPY
Extraordinary incomeInterimDuration11694000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass rounding
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass